跳至主要内容
临床试验/CTRI/2021/07/035137
CTRI/2021/07/035137已完成3 期

AN OPEN CLINICAL TRIAL OF SIDDHA FORMULARY DRUG SWASAKASA NEI IN THE MANAGEMENT OF SWASAKASAM (BRONCHIAL ASTHMA)

ational Institute of Siddha0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • INCLUSIONCRITERIA:
  • 1.Age between 18-60 years.
  • 2.Sex: Male, Female & Transgender.
  • 3.Patients with a clinical symptoms of Sneezing, Rhinitis, Dyspnoea, Cough with or without expectoration, Wheeze, Tightness of chest.
  • 4.Wheezing more than 3 weeks.
  • 5.Night time wheezing more than one day/week.
  • 6.Asthma sometimes interferes with normal daily activities.
  • 7.Patients who are willing to take radiological investigation and provide blood for lab investigation.
  • 8.Patients who are willing to estimate volume of air forcibly expired after a deep inspiration by using PFT.

排除标准

  • 1.Having covid-19 (or) past history of covid-19
  • 2.Restrictive Lung diseases
  • 3.Tuberculosis
  • 4.Emphysema
  • 5.Pleural effusion
  • 6.Pneumothorax
  • 7.Cardiac diseases and Renal diseases
  • 8.Sleep apnea
  • 9.Diabetic mellitus
  • 10.Hypertension
  • 11.Pregnancy
  • 12.Lactation.

研究者

相似试验